BANGALORE and SAN
FRANCISCO, April 15, 2026 :  Miro Biotech today announced the global
availability of its research-grade peptide catalog, extending HPLC-verified
compounds to individual researchers, laboratories, and academic institutions
across India, North America, Latin America, Europe, Africa, Asia-Pacific, and
the Middle East.

Demand for high-purity
research peptides has accelerated across academic and industrial research
groups, driven by expanding in-vitro investigation of metabolic, regenerative,
and pathway-signaling biology. High-purity supply paired with consistent
per-batch analytical documentation has become a procurement priority for
research institutions operating across multiple geographies, particularly in
India and across Asia-Pacific, where domestic laboratory investment has scaled
significantly over the past decade.

“The global research
community is moving faster than its supply chain, and Indian institutions in
particular have built remarkable research capacity over the past decade,” said
Ria Tan, vice president of global operations at Miro Biotech. “Our mandate is
to put verified, high-purity compounds in the hands of qualified investigators
at the pace modern research demands, on every continent we serve. Today’s
release is the first stage of a rapidly expanding catalog, with additional
compounds, expanded analytical capacity, and deepened support for the Indian
research community planned throughout 2026.”

Catalog

The Miro Biotech catalog
currently includes widely studied research peptides such as Retatrutide,
BPC-157, GHK-Cu, CJC-1295, Ipamorelin, and Tesamorelin, alongside
reconstitution solutions for laboratory use. Catalog expansion throughout 2026
will introduce additional metabolic, regenerative, and cognitive pathway
compounds, with new releases scheduled across consecutive quarters. Compound
selection is informed by requests from the international research community and
emerging areas of in-vitro investigation.

Analytical Verification

Every batch released
under the Miro Biotech catalog is independently verified by a third-party
analytical laboratory. Testing is performed using reverse-phase
high-performance liquid chromatography, with a minimum 99 percent purity
specification applied across the catalog. Certificates of analysis are issued
per batch, documenting identity, purity, and appearance testing. Minimum purity
thresholds are enforced at the batch level, and release to the catalog is
contingent on verified analytical conformance.

Research Applications

Metabolic research
compounds in the catalog are used in in-vitro research on glucose regulation,
lipid metabolism, and incretin pathway signaling. Recovery and repair compounds
are used in in-vitro studies of tissue regeneration, extracellular matrix
biology, and wound-healing pathways. Cognitive research compounds are used in
in-vitro investigation of receptor binding and neurochemical pathways.
Anti-aging research compounds are used in in-vitro studies of cellular
senescence, NAD+ metabolism, and cellular aging. Reconstitution solutions
complete the catalog with research-grade carriers suitable for laboratory reconstitution
protocols.

India Research Market

India has emerged as one
of the fastest-growing research markets in the Asia-Pacific region, supported
by increased public investment in life-sciences capacity and a rapidly
expanding academic biotechnology sector. Miro Biotech’s Bangalore operations
support individual researchers, laboratories, and institutions across India
with INR pricing, UPI-enabled procurement, and standard delivery timelines of
seven to fourteen business days. The company’s India footprint is designed to
reduce the cross-border procurement friction that has historically constrained
laboratory research workflows in the region, with domestic distribution
covering Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Pune, Kolkata,
Ahmedabad, and additional research hubs across the country.

Global Distribution

Beyond India, Miro
Biotech delivers worldwide, including to research institutions in the United
States, United Kingdom, Germany, France, Australia,
Japan, South Korea, Brazil, South Africa, and additional international markets.

Availability

The Miro Biotech catalog
is available at www.mirobiotech.com. Orders are accepted for in-vitro research use
only.

About Miro Biotech

Miro Biotech is a leading
peptide biotechnology company with operations in India and the United States,
supplying research-grade peptides and reference compounds to individual
researchers, laboratories, and academic institutions worldwide. With offices in
Bangalore and San Francisco, the company serves the global research community
with HPLC-verified compounds, per-batch certificates of analysis, and
international fulfillment infrastructure. The Miro Biotech catalog is designed
to meet the analytical and logistical requirements of laboratory-grade research
procurement, from independent researchers and academic investigators to
established biotechnology and pharmaceutical research groups. For more
information, visit www.mirobiotech.com.

Research Use Only Notice

All Miro Biotech products
are supplied strictly for in-vitro research use. They are not drugs, medical
devices, cosmetics, food, or dietary supplements, and are not intended for
diagnostic, therapeutic, clinical, or veterinary use. Products are not approved
by the U.S. Food and Drug Administration, the Central Drugs Standard Control
Organisation (CDSCO), or any other regulatory authority for administration to
humans or animals. Purchasers assume sole responsibility for compliance with
applicable laws, institutional policies, and import regulations governing the
handling, storage, and research use of these compounds.